H.Res. 803 · 119th Congress (2025–2027)
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.Res. 803’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. John W. Rose (R-TN-6)
- Cosponsors
11 cosponsors
7 original · 4 later
11 R
- Rep. Sheri Biggs (R-SC-3)· Original · Oct 10, 2025
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Original · Oct 10, 2025
- Rep. Glenn Grothman (R-WI-6)· Original · Oct 10, 2025
- Rep. Diana Harshbarger (R-TN-1)· Original · Oct 10, 2025
- Rep. Harriet M. Hageman (R-WY)· Original · Oct 10, 2025
- Rep. Doug LaMalfa (R-CA-1)· Original · Oct 10, 2025
- Rep. Barry Moore (R-AL-1)· Original · Oct 10, 2025
- Rep. Robert B. Aderholt (R-AL-4)· Later · Oct 17, 2025
- Rep. Andy Harris (R-MD-1)· Later · Oct 28, 2025
- Rep. Ben Cline (R-VA-6)· Later · Nov 4, 2025
- Rep. Michael Guest (R-MS-3)· Later · Nov 4, 2025
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Submitted in House
Document: Introduced in House
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (1)
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Official title, Display title · Introduced in House